If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Update on Continuation Proposals

14 Jan 2016 07:00

RNS Number : 8126L
BlueCrest AllBlue Fund Ltd
14 January 2016
 



 

BlueCrest AllBlue Fund Limited (the "Company")

14 January 2016

Update on Continuation Proposals

Further to the Company's announcement on 9 December 2015, the Board is pleased to announce that, having completed its review of manager proposals received by the Company and consulted with its major shareholders, it proposes to recommend the replacement of its existing management arrangements with a mandate given to J.P. Morgan Asset Management ("JPMAM") group(1). The proposed appointment is subject to, amongst other things, detailed due diligence which is being performed on behalf of the Company and finalisation of engagement terms. In addition, the proposed appointment will be subject to shareholder approval as part of the re-organisation proposals (the "Proposals") to be put forward in due course.

As part of the Proposals, it is intended that the Company will invest substantially all of its assets (net of the cash exit opportunity described below) in the Highbridge Multi-Strategy Fund ("HMSF"). HMSF is a global multi-strategy hedge fund, managed by Highbridge Capital Management ("HCM"), focused on relative value strategies with idiosyncratic sources of return that invests in 12 distinct strategies across Fundamental Equity, Quantitative Equity, Event Driven Equity, Capital Structure Arbitrage, Convertible & Volatility Arbitrage, Fundamental Credit and Macro. Since its inception (1 January 1993) HMSF has achieved 10.76% annualised net returns, 6.89% annualised volatility and low beta relative to equity and credit indices.(2)

The JPMAM group is the largest manager of closed-end investment companies in the UK with 23 investment companies under its management and £9.2bn of assets under management(3). HCM was founded in 1992 as one of the industry's first multi-strategy hedge fund managers. Today, it is a global alternative investment manager with $29 billion in AUM(4). HCM maintains a staff of over 380 employees, including ~150 investment professionals and has offices in London, New York and Hong Kong.(4) HCM established a strategic partnership with JPMAM in 2004. All investment, capital allocation and risk management decisions for HMSF are independent of JPMAM.

It is currently intended to put forward the Proposals by the end of January/early February. As previously announced, the Proposals will provide shareholders with an opportunity to receive a full cash exit at NAV less costs (the "Cash Exit"), representing the net realisation proceeds from the AllBlue Limited redemptions, as soon as practicable following receipt by the Company. Proceeds of AllBlue Limited assets not capable of immediate realisation will subsequently be invested into HMSF with the exception of those proceeds due to shareholders pursuant to the Cash Exit.

Following implementation of the Proposals, it is intended to introduce a quarterly redemption facility, for up to 20% of the prevailing net asset value of the Company at NAV less costs, which may be implemented at the Board's discretion in each quarterly period. It is intended that net redemption proceeds would be paid to shareholders as soon as practicable following receipt by the Company.

A further announcement in relation to the Proposals will be made in due course.

For further information contact:

JTC (Guernsey) Limited, Secretary

Tel: +44 (0) 1481 702 400

Jefferies International Limited

Gary Gould/ Alex Collins

Tel: + 44 (0) 20 7029 8000

Dexion Capital Plc

Robin Bowie/ Katie Standley

Tel: +44 (0) 20 7832 0900

 

 

PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS

There can be no assurance that the Company's or HMSF's return objectives will be realized or that the Company or HMSF will not experience losses.

 

(1) The brand name for the Asset Management business of J.P. Morgan Chase & Co.

(2) As of 30 November 2015 net of all applicable fees and expenses. Returns are estimated and unaudited for 2015.

(3) As of 31 December 2015.

(4) As of 1 December 2015.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUOUKRNWAAAAR
Date   Source Headline
1st Jun 20174:56 pmRNSHolding(s) in Company
1st Jun 20174:32 pmRNSHolding(s) in Company
1st Jun 20171:32 pmRNSHolding(s) in Company
31st May 201710:50 amRNSNet Asset Value(s)
23rd May 201711:50 amRNSNet Asset Value(s)
23rd May 20179:51 amRNSEstimated Creditor Interests
23rd May 20179:48 amRNSNet Asset Value(s)
16th May 201711:12 amRNSNet Asset Value(s)
10th May 20174:40 pmRNSConfirmation of AllBlue Proceeds Received
9th May 201711:07 amRNSNet Asset Value(s)
3rd May 201710:46 amRNSNet Asset Value(s)
2nd May 201710:05 amRNSInvestor Communication from AllBlue Limited
2nd May 20179:57 amRNSTender Offer and Buyback Programme
28th Apr 201712:34 pmRNSEstimated Creditor Interests
28th Apr 201712:25 pmRNSNet Asset Value(s)
25th Apr 201711:17 amRNSNet Asset Value(s)
20th Apr 20177:00 amRNSHolding(s) in Company
19th Apr 201711:29 amRNSNet Asset Value(s)
11th Apr 201711:58 amRNSNet Asset Value(s)
5th Apr 20175:18 pmRNSHolding(s) in Company
5th Apr 201710:01 amRNSNet Asset Value(s)
4th Apr 20175:22 pmRNSHolding(s) in Company
3rd Apr 201711:51 amRNSAnnual Financial Report and Notice of AGM
3rd Apr 201711:37 amRNSDirector Declaration
30th Mar 20173:53 pmRNSCash Received Update
28th Mar 201711:34 amRNSNet Asset Value(s)
24th Mar 201712:26 pmRNSEstimated Creditor Interests
24th Mar 201711:39 amRNSNet Asset Value(s)
21st Mar 201710:25 amRNSNet Asset Value(s)
14th Mar 201711:11 amRNSNet Asset Value(s)
10th Mar 20175:34 pmRNSTransaction in Own Shares
10th Mar 20172:42 pmRNSAppointment of Corporate Broker
7th Mar 201712:11 pmRNSNet Asset Value(s)
3rd Mar 201712:28 pmRNSNet Asset Value(s)
3rd Mar 201712:17 pmRNSHolding(s) in Company
3rd Mar 201712:16 pmRNSHolding(s) in Company
3rd Mar 201712:15 pmRNSHolding(s) in Company
2nd Mar 20172:00 pmRNSEstimated Creditor Interests
2nd Mar 20171:59 pmRNSNet Asset Value(s)
28th Feb 201712:34 pmRNSNet Asset Value(s)
22nd Feb 20175:11 pmRNSHolding(s) in Company
22nd Feb 201712:31 pmRNSNet Asset Value(s)
17th Feb 20175:44 pmRNSTransaction in Own Shares
15th Feb 20174:04 pmRNSConfirmation of Tender Offer Payments
14th Feb 20171:05 pmRNSNet Asset Value(s)
10th Feb 20175:28 pmRNSTransaction in Own Shares
9th Feb 20176:15 pmRNSCreditor Interest Update - clarification
9th Feb 20173:49 pmRNSEstimated Creditor Interests
8th Feb 20171:53 pmRNSHolding(s) in Company
7th Feb 20174:09 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.